ABG 100 (Morphine sulphate extended-release 100 mg)
Pill imprint ABG 100 has been identified as Morphine sulphate extended-release 100 mg.
Morphine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 100 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
- ABG 100
- 100 mg
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Watson Pharmaceuticals
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00591-3743||Watson Pharmaceuticals, Inc. (now Actavis, Inc)|
|55887-0094||Diversified Healthcare Services Inc (repackager)|
|54868-5590||Physicians Total Care Inc (repackager)|
|16590-0696||Stat RX USA LLC (repackager)|
|16590-0921||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about morphine
- Morphine concentrate
- Morphine extended-release capsules
- Morphine immediate-release
- Morphine immediate-release tablets
- More (8) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.